Seoul St. Mary's hospital
Seoul, 06591, South Korea
NCT Number: NCT06280898
Divided into two groups based on acute kidney injury: non-acute kidney injury group vs. non-acute kidney injury group. Acute kidney injury group, Acute Kidney Injury Network (AKIN), Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease (RIFLE), or Kidney Disease: Improving Global Outcomes (KDIGO) I would like to divide it according to the definition. After testing the normal distribution of patients, donors, grafts, types of immunosuppressants, surgery/anesthesia factors, and blood test findings between the two groups through the Shapiro-Wilk test, continuous data was tested using the student t-test or Mann-Whitney U test. Sizes are compared using , and categorical data is compared with proportions using the χ2 test or Fisher's exact test. Analysis of factors related to acute kidney injury will be performed through univariate and multivariate logistic regression analysis.
Looking for future studies?
Notify Me19 year–80 year
All sexes
Observational
Seoul, 06591, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Remote ischemic condition
Time frame: up to 24 hour postoperatively
Troponin I difference in two groups
Time frame: up to 24 hour postoperatively
Troponin T difference in two groups
Time frame: up to 24 hour postoperatively
OTc interval difference in two groups
Seoul St. Mary's Hospital
Other
Analysis of Perioperative Factors Affecting Early Postoperative Kidney Graft Function Recovery in Patients Undergoing Living Kidney Transplant Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03461588
Breast Diseases, Breast Neoplasms
Beijing, China
View Trial DetailsNCT03532919
Cardiovascular Diseases, Female Urogenital Diseases
Mölndal, Västra Götaland County, Sweden
View Trial DetailsNCT00823160
Cardiovascular Diseases, Heart Diseases
Cape Town, Western Cape, South Africa
View Trial DetailsNCT07685860
Anxiety, Anxiety Disorders
Hefei, Anhui, China
View Trial Details